Dec 05, 2016 12:30 pm UTC| Business
SAN DIEGO, Dec. 05, 2016 -- TG Therapeutics, Inc. (NASDAQ:TGTX), announced the presentation yesterday of two preclinical data sets, one oral presentation and one poster presentation, for TGR-1202, the Company’s...
KaloBios Highlights Priority Milestones in Letter to Stakeholders
Dec 05, 2016 12:30 pm UTC| Business
BRISBANE, Calif., Dec. 05, 2016 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, MD,...
Caladrius Biosciences to Present at Upcoming December Conferences
Dec 05, 2016 12:30 pm UTC| Business
BASKING RIDGE, N.J., Dec. 05, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining a select therapeutic development pipeline with an industry-leading...
Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study
Dec 05, 2016 12:30 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Dec. 05, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated a study of its NY‑ESO SPEAR™...
Centennial Resource Development Announces Commitments for $910 Million Private Placement of Equity
Dec 05, 2016 12:05 pm UTC| Business
DENVER, Dec. 05, 2016 -- Centennial Resource Development, Inc. together with its affiliates (“CDEV”, “Centennial” or the “Company”) (NASDAQ:CDEV) (NASDAQ:CDEVW), today announced that it has entered into agreements to...
Dec 05, 2016 12:05 pm UTC| Business
– MAT2501 previously received Orphan Drug and Qualified Infectious Disease Product designations for treatment of nontuberculous mycobacterium infections by U.S. FDA – – Phase 1 data expected in the first half of 2017 –...
Dec 05, 2016 12:04 pm UTC| Business
WATERTOWN, Mass., Dec. 05, 2016 -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing a novel class of targeted antigen-specific immune therapies, announced today that it will...